Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-  Pathway

Peroxisome proliferator-activated receptor delta (PPAR-8) is a nuclear receptor transcription factor that regulates gene expression during development and disease states, such as cancer. However, the precise role of PPAR-8 during tumorigenesis is not well understood. Recent data suggest that PPAR-8...

Full description

Bibliographic Details
Main Authors: Beyaz, Semir (Contributor), Yilmaz, Omer (Contributor)
Other Authors: Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Association for Cancer Research (AACR), 2018-07-23T19:07:24Z.
Subjects:
Online Access:Get fulltext
LEADER 01877 am a22001933u 4500
001 117054
042 |a dc 
100 1 0 |a Beyaz, Semir  |e author 
100 1 0 |a Koch Institute for Integrative Cancer Research at MIT  |e contributor 
100 1 0 |a Beyaz, Semir  |e contributor 
100 1 0 |a Yilmaz, Omer  |e contributor 
700 1 0 |a Yilmaz, Omer  |e author 
245 0 0 |a Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-  Pathway 
260 |b American Association for Cancer Research (AACR),   |c 2018-07-23T19:07:24Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/117054 
520 |a Peroxisome proliferator-activated receptor delta (PPAR-8) is a nuclear receptor transcription factor that regulates gene expression during development and disease states, such as cancer. However, the precise role of PPAR-8 during tumorigenesis is not well understood. Recent data suggest that PPAR-8 may have context-specific oncogenic and tumor-suppressive roles depending on the tissue, cell-type, or diet-induced physiology in question. For example, in the intestine, pro-obesity diets, such as a high-fat diet (HFD), are associated with increased colorectal cancer incidence. Interestingly, many of the effects of an HFD in the stem and progenitor cell compartment are driven by a robust PPAR-8 program and contribute to the early steps of intestinal tumorigenesis. Importantly, the PPAR-8 pathway or its downstream mediators may serve as therapeutic intervention points or biomarkers in colon cancer that arise in patients who are obese. Although potent PPAR-8 agonists and antagonists exist, their clinical utility may be enhanced by uncovering how PPAR-8 mediates tumorigenesis in diverse tissues and cell types as well as in response to diet. 
520 |a National Institutes of Health (U.S.) (Grant R00-AG045144) 
655 7 |a Article 
773 |t Clinical Cancer Research